Studies Reveal New Protein Target For Treating Alzheimer’s Disease
Studies Reveal New Protein Target For Treating Alzheimer’s Disease
Three new studies provide converging evidence pointing to a new therapeutic target in Alzheimer’s Disease(AD). These studies, from independent academic centers in the U.S., England, and China, point to excess levels of a protein called TNF as a key factor in… Continue reading
Detecting Symptoms of Alzheimer’s in Your Loved One’s Behavior
Detecting Symptoms of Alzheimer’s in Your Loved One’s Behavior
Cognitive symptoms of Alzheimer’s disease include disruption of the memory, language, thinking and reasoning skills. These are the most noticeable effects of the disease, but there are also many other additional behavioral and psychiatric symptoms that occur in most individuals with… Continue reading
Drug Linked to Alzheimer’s
Research published today is suggesting that a commonly prescribed drug to control blood sugar might increase the risk of Alzheimer’s. But it also suggests that using the drug in combination with insulin might reduce the risk. www.sciencentral.com
Video Rating: 4 / 5
Fayette County: Alzheimer’s center needs volunteers
Fayette County: Alzheimer’s center needs volunteers
The Alzheimer’s Association is in need of volunteers to help at the Best Friends Day Center loc
Read more on Lexington Herald-Leader
New start for Stone House
The Stone House in Santa Rosa, built in 1909, has been everything from a boarding house and… Continue reading
Discussing Effective Means For Early Alzheimers Treatment
Discussing Effective Means For Early Alzheimers Treatment
Did you know that you could be under 65 and still have Alzheimers Disease? Early Alzheimers affects roughly 200,000 Americans and accounts for 5-10% of all Alzheimers cases. Unlike other forms of the disease, this type generally runs in families and is linked… Continue reading
Alzheimer’s Drug Discovery Foundation Funds AgeneBio to Advance Pharmacological Neural Stabilizer Technology
Alzheimer’s Drug Discovery Foundation Funds AgeneBio to Advance Pharmacological Neural Stabilizer Technology
NEW YORK, Aug. 26 /PRNewswire-USNewswire/ — The Alzheimer’s Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of 0,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic… Continue reading